431 related articles for article (PubMed ID: 22931788)
21. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
[TBL] [Abstract][Full Text] [Related]
22. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
Zhang K; Li L; Qi Y; Zhu X; Gan B; DePinho RA; Averitt T; Guo S
Endocrinology; 2012 Feb; 153(2):631-46. PubMed ID: 22147007
[TBL] [Abstract][Full Text] [Related]
23. Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution.
Hinman RM; Nichols WA; Diaz TM; Gallardo TD; Castrillon DH; Satterthwaite AB
Int Immunol; 2009 Jul; 21(7):831-42. PubMed ID: 19502585
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways.
Zhang J; Ng S; Wang J; Zhou J; Tan SH; Yang N; Lin Q; Xia D; Shen HM
Autophagy; 2015 Apr; 11(4):629-42. PubMed ID: 25919885
[TBL] [Abstract][Full Text] [Related]
25. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease.
Du X; Shi H; Li J; Dong Y; Liang J; Ye J; Kong S; Zhang S; Zhong T; Yuan Z; Xu T; Zhuang Y; Zheng B; Geng JG; Tao W
J Immunol; 2014 Feb; 192(4):1525-35. PubMed ID: 24453252
[TBL] [Abstract][Full Text] [Related]
26. Novel Foxo1-dependent transcriptional programs control T(reg) cell function.
Ouyang W; Liao W; Luo CT; Yin N; Huse M; Kim MV; Peng M; Chan P; Ma Q; Mo Y; Meijer D; Zhao K; Rudensky AY; Atwal G; Zhang MQ; Li MO
Nature; 2012 Nov; 491(7425):554-9. PubMed ID: 23135404
[TBL] [Abstract][Full Text] [Related]
27. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.
Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH
Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808
[TBL] [Abstract][Full Text] [Related]
28. Regulation of FOXO1 by TAK1-Nemo-like kinase pathway.
Kim S; Kim Y; Lee J; Chung J
J Biol Chem; 2010 Mar; 285(11):8122-9. PubMed ID: 20061393
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway.
Boreddy SR; Pramanik KC; Srivastava SK
Clin Cancer Res; 2011 Apr; 17(7):1784-95. PubMed ID: 21350002
[TBL] [Abstract][Full Text] [Related]
30. The Transcriptional Regulation of FOXO Genes in Thyrocytes.
Franz F; Weidinger C; Krause K; Gimm O; Dralle H; Führer D
Horm Metab Res; 2016 Sep; 48(9):601-6. PubMed ID: 27258970
[TBL] [Abstract][Full Text] [Related]
31. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia.
Lee JW; Nam H; Kim LE; Jeon Y; Min H; Ha S; Lee Y; Kim SY; Lee SJ; Kim EK; Yu SW
Autophagy; 2019 May; 15(5):753-770. PubMed ID: 30523761
[TBL] [Abstract][Full Text] [Related]
32. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
[TBL] [Abstract][Full Text] [Related]
33. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
[TBL] [Abstract][Full Text] [Related]
34. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.
Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA
Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820
[TBL] [Abstract][Full Text] [Related]
35. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
36. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
37. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
[TBL] [Abstract][Full Text] [Related]
38. The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.
Stahl M; Dijkers PF; Kops GJ; Lens SM; Coffer PJ; Burgering BM; Medema RH
J Immunol; 2002 May; 168(10):5024-31. PubMed ID: 11994454
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol decreases FoXO protein expression through PI3K-Akt-dependent pathway inhibition in H₂O₂-treated synoviocytes.
Xu B; Wang G; Zhang J; Cao W; Chen X
Histol Histopathol; 2017 Dec; 32(12):1305-1315. PubMed ID: 28211035
[TBL] [Abstract][Full Text] [Related]
40. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.
Zhao J; Brault JJ; Schild A; Cao P; Sandri M; Schiaffino S; Lecker SH; Goldberg AL
Cell Metab; 2007 Dec; 6(6):472-83. PubMed ID: 18054316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]